Literature DB >> 23109414

Painful ophthalmoplegia with simultaneous orbital myositis, optic and oculomotor nerve inflammation and trigeminal nucleus involvement in a patient with herpes zoster ophthalmicus.

Georgios P Paraskevas1, Evangelos Anagnostou, Sofia Vassilopoulou, Konstantinos Spengos.   

Abstract

Viral infection is a rare cause of painful ophthalmoplegia. We report on a 67-year-old patient who developed painful double vision after a vesicular skin rash on the left forehead. MRI disclosed simultaneous inflammatory lesions in all extraocular muscles, the second and third cranial nerve, as well as pathological signal intensity along the spinal trigeminal tract and nucleus within the medulla oblongata and the pons. Cerebrospinal fluid and serum tests for varicella zoster were positive. The patient was treated effectively with intravenous acyclovir and methylprednisolone. Simultaneous lesions in various neighbouring neural structures may be characteristic for the highly neurotropic behaviour of the herpesviridae and should be considered as a cause of painful ophthalmoplegia that can be depicted by appropriate imaging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23109414      PMCID: PMC4543994          DOI: 10.1136/bcr-2012-007063

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Herpes zoster opthalmicus with complete external ophthalmoplegia.

Authors:  R K Garg; A M Kar; A K Jain
Journal:  J Assoc Physicians India       Date:  1992-07

2.  Orbital myositis involving the oblique muscles associated with herpes zoster ophthalmicus.

Authors:  Jaime Badilla; Peter J Dolman
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2007 Sep-Oct       Impact factor: 1.746

3.  A rare case of herpes zoster ophthalmicus with complete ophthalmoplegia.

Authors:  Xu Hui Ying; Ajeet M Wagle; Lawrence Tan; Srinivasan Sanjay; Smita R Hedge; Yip Chee Chew; Philip Yap
Journal:  J Am Geriatr Soc       Date:  2008-11       Impact factor: 5.562

4.  Histopathology of herpes zoster ophthalmicus.

Authors:  G Naumann; J D Gass; R L Font
Journal:  Am J Ophthalmol       Date:  1968-04       Impact factor: 5.258

5.  Herpes zoster ophthalmicus and the orbital apex syndrome.

Authors:  R D Bourke; J Pyle
Journal:  Aust N Z J Ophthalmol       Date:  1994-02

6.  Transgenic targeting of recombinant rabies virus reveals monosynaptic connectivity of specific neurons.

Authors:  Aldis P Weible; Leslie Schwarcz; Ian R Wickersham; Leah Deblander; Haiyan Wu; Edward M Callaway; H Sebastian Seung; Clifford G Kentros
Journal:  J Neurosci       Date:  2010-12-08       Impact factor: 6.167

7.  An unusual presentation of herpes zoster ophthalmicus: orbital myositis preceding vesicular eruption.

Authors:  Aki Kawasaki; François-Xavier Borruat
Journal:  Am J Ophthalmol       Date:  2003-09       Impact factor: 5.258

Review 8.  External ocular motor palsies in ophthalmic zoster: a review.

Authors:  R J Marsh; B Dulley; V Kelly
Journal:  Br J Ophthalmol       Date:  1977-11       Impact factor: 4.638

9.  Complete ophthalmoplegia with pupillary involvement as an initial clinical presentation of herpes zoster ophthalmicus.

Authors:  Tayson Delengocky; Christina M Bui
Journal:  J Am Osteopath Assoc       Date:  2008-10

10.  External ophthalmoplegia due to ocular myositis in a patient with ophthalmic herpes zoster.

Authors:  M Krasnianski; M Sievert; V Bau; S Zierz
Journal:  Neuromuscul Disord       Date:  2004-07       Impact factor: 4.296

View more
  2 in total

1.  Shingles as the underlying cause of orbital myositis in an adolescent: A case report.

Authors:  Christopher D Conrady; Richard M Feist; Alison Crum
Journal:  Am J Ophthalmol Case Rep       Date:  2016-12-30

2.  Isolated optic neuritis with a concurrent abnormal trigeminal nucleus on imaging: case report of a rare complication of herpes zoster ophthalmicus.

Authors:  Kavin Vanikieti; Anuchit Poonyathalang; Panitha Jindahra; Piyaphon Cheecharoen; Patchalin Patputtipong; Tanyatuth Padungkiatsagul
Journal:  BMC Neurol       Date:  2018-10-04       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.